# Aqueous humor cytokines levels and illuminated microcatheter-assisted circumferential trabeculotomy outcome in open-angle glaucoma patients: a 24-month prospective study

**Authors:** Tingyi Wu, Qianqian Ji, Yanfeng Liao, Xiaoyu Zhao, Ying Hong

PMC · DOI: 10.3389/fimmu.2025.1575909 · Frontiers in Immunology · 2025-05-20

## TL;DR

This study found that higher levels of certain cytokines in the eye fluid of glaucoma patients are linked to worse outcomes after a specific type of surgery.

## Contribution

The study identifies specific cytokines and a chemokine signaling pathway associated with surgical failure in open-angle glaucoma patients.

## Key findings

- Higher levels of CCL2, ICAM-1, IL-6, and CXCL10 in aqueous humor correlate with surgical failure.
- Chemokine signaling pathway is potentially linked to the outcome of trabeculotomy surgery.
- Secondary glaucoma, younger age, and higher preoperative IOP are risk factors for surgical failure.

## Abstract

To investigate the influence of aqueous humor cytokines levels on the failure of illuminated microcatheter-assisted circumferential trabeculotomy (MAT) in open-angle glaucoma (OAG) patients.

This was a prospective case series with a follow-up period of 24 months. General information and ocular examinations were recorded. Aqueous humor was collected at the time of surgery. Eight aqueous humor cytokines were analyzed: CCL2, VCAM-1, ICAM-1, IL-6, IL-8, IL-10, CXCL10 and G-CSF. Bioinformatics analysis was used to explore the protein network and the possible pathways related to OAG. Surgical failure was defined as a requirement for glaucoma reoperation or intraocular pressure (IOP) greater than 21mmHg with more than 3 topical antiglaucoma medications at 24-month follow-up.

Sixty-five eyes were enrolled (58 success and 7 failure). The levels of CCL2, ICAM-1, IL-6 and CXCL10 in aqueous humor were significantly higher in the surgical failure group (P = 0.024, 0.002, 0.022 and 0.008, respectively). A higher percentage of secondary glaucoma (P < 0.001), younger age (P = 0.019), worse preoperative BCVA (P = 0.022), higher preoperative IOP (P = 0.022) and more preoperative topical antiglaucoma medications (P = 0.029) were significantly observed in the surgical failure group. Bioinformatics analysis identified 4 hub proteins, including CCL2, CXCL10, IL-6 and CXCR3, and demonstrated the potential role of chemokine signaling pathway in MAT surgical outcome.

Higher concentrations of CCL2, ICAM-1, IL-6 and CXCL10 in the aqueous humor were related to the failure of MAT surgery in OAG patients, and chemokine signaling pathway might be associated with the surgical outcome.

## Linked entities

- **Proteins:** CCL2 (C-C motif chemokine ligand 2), VCAM1 (vascular cell adhesion molecule 1), ICAM1 (intercellular adhesion molecule 1), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL10 (interleukin 10), CXCL10 (C-X-C motif chemokine ligand 10), CSF3 (colony stimulating factor 3), CXCR3 (C-X-C motif chemokine receptor 3)
- **Diseases:** open-angle glaucoma (MONDO:0005338)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}
- **Diseases:** OAG (MESH:D005902), glaucoma (MESH:D005901)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12129756/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12129756/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12129756/full.md

---
Source: https://tomesphere.com/paper/PMC12129756